DeepMind is holding back release of AI research to give Google an edge
Google’s artificial intelligence arm DeepMind has been holding back the release of its world-renowned research, as it seeks ...
Inside Google’s Two-Year Frenzy to Catch Up With OpenAI
The search giant should’ve been first to the chatbot revolution. It wasn’t. So it punched back with late nights, layoffs—and ...
Alphabet’s AI Drug Unit Raises $600 Million From OpenAI Backer
Isomorphic Labs, the Alphabet Inc.-owned company that uses artificial intelligence to discover drugs, has raised $600 million ...
Isomorphic Labs, Google’s A.I. Drug Business, Raises $600 Million
The company, which uses artificial intelligence to develop new treatments, now counts the venture capital firm Thrive Capital ...
NewsBytes1d
Why Google's AI products fail to go viral like OpenAI's
Despite Google's technically superior AI tools, they consistently fail to garner the same global attention as OpenAI and ...
Investing.com UK1d
Google’s DeepMind slows research publications to maintain AI edge – FT
Investing.com-- Google’s (NASDAQ: GOOGL) artificial intelligence research arm, DeepMind, has imposed stricter controls on the ...
Alphabet spinout Isomorphic Labs raises $600M for its AI drug design engine
AlphaFold 3, the improved version of the model used by Isomorphic Labs’ drug design engine, debuted last May. It can predict ...
GEN - Genetic Engineering and Biotechnology News1d
DeepMind Spinout Isomorphic Labs Raises $600M Toward AI Drug Design
Isomorphic Labs says it is advancing drug design programs across multiple therapeutic areas and drug modalities. These ...
The Information13d
Google DeepMind’s Expanding Org
As Google attempts to catch up to OpenAI’s ChatGPT, its DeepMind artificial intelligence unit is in a near constant state of ...